Evidence map›Paper›PMID 41430272›Full record

ReviewCell communication and signaling : CCS2025

Xist in X chromosome inactivation: mechanisms and disease relevance.

Xiaona Zhang, Qie Mu, Jing Wang, Yuqing Sun, Rui Cao, Lixiao Guo, Qi Han, Jiaojiao Gao, Baofeng Yu, Xiuwei Wang and 2 more

Abstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Mechanistic insights into the lncRNA-Notch signaling axis in tumors.Frontiers in cell and developmental biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaona Zhang *Department of Hepatobiliary Surgery and Liver Transplant Center, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Qie Mu *Department of Hepatobiliary Surgery and Liver Transplant Center, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Jing WangDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Yuqing SunDepartment of Hepatobiliary Surgery and Liver Transplant Center, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Rui CaoDepartment of Conversion Center, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Lixiao GuoShanxi Provincial People's Hospital, Taiyuan, Shanxi, 030001, China.
Qi HanDepartment of Hepatobiliary Surgery and Liver Transplant Center, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Jiaojiao GaoDepartment of Biological and Food Engineering, Lyuliang University, Lvliang, 033001, Shanxi, China.
Baofeng YuDepartment of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, Shanxi, 030001, China. shanxiyangcheng@126.com.
Xiuwei WangBeijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Institute of Pediatrics, Beijing, 100020, China. wangxiuwei1010@126.com.
Li ZhangDepartment of Hepatobiliary Surgery and Liver Transplant Center, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China. zhangli3788@163.com.
Huaxing MengDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China. menghuaxing@126.com.

Funding

Key R&D Project of Lvliang City, Shanxi Province 2024SHFZ14National Natural Science Foundation of China 82201319National Natural Science Foundation of China 82400677Natural Science Foundation of Beijing Municipality 7182025Natural Science Foundation of Shanxi Province 202403021221155Natural Science Foundation of Shanxi Province,China 202203021212043,202203021221245,202403021221156Open Fund from Key Laboratory of Cellular Physiology (Shanxi Medical University), Ministry of Education, China CPOF202301Sanjin Elite Youth Top notch Talent Project fund SJYC2024439Science Research Start-up Fund for Doctors of Shanxi Medical University,China XD2005, BYJL063, and SD2004
6 · The paper itself

Abstract

X-inactive specific transcript (Xist) is a main regulator of X chromosome inactivation in mammals, which silences most genes on X chromosome in a cis way. Xist is a kind of lncRNA, which cannot encode the transcript of protein. In addition, Xist RNA mediates the X chromosome inactivation (XCI) process to achieve dose compensation between the sexes. Recent studies have identified that Xist RNA regulates gene expression by recruiting factors/complexes to modify potential chromatin, which were involved in diseases such as neuroinflammation, autoimmune diseases and cancers. In this paper, the research progress of Xist RNA causing a series of diseases in mammalian cells is reviewed, which makes it a potential target for treating human diseases and provides a new direction for further study of diseases.

Indexed as

RNA, Long NoncodingX Chromosome InactivationAnimalsHumansRNA, Long NoncodingXIST non-coding RNAChromatinDosage compensationEpigeneticX chromosome inactivationX-inactive specific transcriptXist activatorsXist repressors

Identifiers

PMID41430272
PMCPMC12723843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.